## Abstract The expression of receptor activator of nuclear factorβΞΊB ligand (RANKL) is regulated by boneβseeking hormones such as PTH and 1Ξ±,25βdihydroxyvitamin D~3~ (1,25(OH)~2~D~3~). Runx2, a master gene for osteoblastic differentiation, also modulates osteoclastogenesis by regulating the RANKL
Vitamin D3 regulation of body fat, cytokines, and calpain gene expression
β Scribed by Hyuck Choi; Kyuho Myung
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 270 KB
- Volume
- 92
- Category
- Article
- ISSN
- 0022-5142
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Because of its prominent expression in central nervous system inflammatory pathology by astrocytes, we examined the mechanism of human IP-10 (hIP-10) gene induction by interferon-gamma (IFN-gamma) and tumor necrosis factor-alpha (TNF-alpha) in astrocytoma cells. When present together, IFN-gamma and
The unique hereditary enamel defect clearly related to the disturbance of one enamel matrix protein is X-linked amelogenesis imperfecta (AI), in which several mutations of amelogenin gene have been identified. The clinical phenotype of many of these subjects shows similarities with enamel defects re
Core binding factor alpha 1 (Cbfa1) is an osteoblast-specific transcription factor essential to develop a mature osteoblast phenotype. However, its exact role in the signaling of various osteotropic-differentiating agents is still unclear. In this study, we assessed the effects of 1,25-(OH)(2)-D3 (D
## Abstract Prostate cancer (PCa) cells express vitamin D receptors (VDR) and 1,25βdihydroxyvitamin D~3~ (1,25(OH)~2~D~3~) inhibits the growth of epithelial cells derived from normal, benign prostate hyperplasia, and PCa as well as established PCa cell lines. The growth inhibitory effects of 1,25(O